IRVINE, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) announced today that Fitch Ratings issued a Spotlight Series report on December 21, 2017 highlighting Sabra’s BBB- rating that was affirmed on September 26, 2017.
The report identified several key ratings drivers including improved tenant diversification and capital markets relevance from the CCP merger; expected improvement in quality, scale and diversification from the Enlivant and North American Healthcare transactions; expected quality improvement from anticipated Genesis dispositions; and a well positioned management team.
Fitch Ratings Spotlight Series can be found on its website at www.fitchratings.com.
About Sabra
Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.
CONTACT:
Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com